Monitoring Anti-p53 Antibodies in Patients with Laryngeal Squamous Cell Carcinoma: Response to Surgical Treatment

Zusman I. , Ben-Hur H. Serological markers for detection of cancer. Int J Mol Med 2001; 7: 547–56.

Numa F. , Umayahara K. , Suehiro Y. Serum anti-p53 antibodies in uterine and ovarian cancer: association with DNA sequence copy number abnormalities. Tumor Biol 2001; 22: 162–8.

Duffy M.J. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38: 225–62.

Creaney J. , Mc Laren B.M. , Stevenson S. P53 autoantibodies in patients with malignant mesothelioma: stability through disease progression. Br J Cancer 2001; 84: 52–6.

Parashar K. , Sobti R.C. A study on p53 protein and anti-53 antibodies in the sera of patients with oesophageal cancer. Mutat Res 1998; 422: 271–7.

Gottschlich S. , Folz B.J. , Goeroegh T. , Lippert B.M. , Maas J.D. , Werner J.A. A new prognostic indicator for head and neck cancer - p53 antibodies? Anticancer Res 1999; 19: 2703–5.

Wollenberg B. , Jan N.V. , Reiter P. , Stieber P. Anti-p53 antibodies in serum of smokers and head and neck cancer patients. Anticancer Res 1997; 17: 413–8.

Bourhis J. , Lubin R. , Roche B. Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 1996; 88: 1228–33.

Soussi T. P53 antibodies in the sera of patients with various types of cancer: a review. Cancer Res 2000; 60: 1777–88.

Mudenda B. , Green J.A. , Green B. The relationship between serum p53 autoantibodies and characteristics of human breast cancer. Br J Cancer 1994, 69: 1115–9.

Zalcman G. , Schlichtholtz B. , Tredaniel J. Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment. Clin Canc Res 1998; 4: 1359–66.